RxDoctor Payments DataLook up a doctor →

Sara Frazier, PA

Neurology · Layton, UTNPI 1427417039

Payments from drug & device makers

$8,000in general payments, 2019–2025

Across 410 payments — averaging $19.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • SK Life Science, Inc.$930
  • Argenx US, Inc.$705
  • UCB, Inc.$618
  • Lilly USA, LLC$459
  • Novartis$408
  • plus $3K from 40 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie102$1,454
SK Life Science, Inc.35$930
Argenx US, Inc.25$705
UCB, Inc.28$618
Lilly USA, LLC28$459
Novartis22$408
EMD Serono, Inc.17$388
Neurocrine Biosciences, Inc.18$341
Biogen11$244
Amneal Pharmaceuticals LLC18$240
Eisai Inc.7$161
Takeda Pharmaceuticals U.S.A., Inc.6$153
Bristol Myers Squibb7$138
TG Therapeutics, Inc.5$133
Neurelis, Inc.6$131
Acadia Pharmaceuticals Inc5$118
Pfizer5$107
CSL Behring4$90
Banner Life Sciences, LLC5$88
Teva Pharmaceuticals USA, Inc.5$85
Amgen4$72
AstraZeneca(2 entities)4$68
Lundbeck LLC4$62
Cycle Pharmaceuticals Inc3$62
Genentech USA, Inc.3$60
Livanova USA, Inc.3$55
Jazz Pharmaceuticals Inc.3$53
Biohaven Pharmaceuticals, Inc.2$51
Medtronic1$49
Cala Health, Inc.2$45
Averitas Pharma Inc.1$41
MDD US Operations, LLC2$41
Sunovion Pharmaceuticals Inc.3$36
Sanofi2$36
Vanda Pharmaceuticals Inc.1$34
E.r. Squibb & Sons, L.L.C.2$31
Boston Scientific2$28
Johnson & Johnson1$26
Catalyst Pharmaceuticals, Inc.1$24
Adamas Pharmaceuticals, Inc.1$23
Grifols USA, LLC1$23
Axsome Therapeutics, Inc.1$23
Merz Pharmaceuticals, LLC1$18
Tanabe Pharma America, Inc.1$18
Xeris Pharmaceuticals, Inc.1$17
Inspire Medical Systems, Inc.1$14

How this compares

$8,000 in reported general payments places this provider in the 70th percentile of 157 neurology providers in Utah.

See all neurology providers in Utah →

Medicare billing

Part B allowed, 2024
$12,302
Medicare patients
79
Services billed
395

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology in Layton

See the full list for Utah →

Where these figures come from

Is this you, or does something look wrong? →